EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.6.1.49 | 3-(3,4-dihydroxyphenyl)-L-alanine + 2-oxoglutarate |
i.e. L-dopa |
Cavia porcellus |
3-(3,4-dihydroxyphenyl)pyruvate + L-glutamate |
i.e. DOPP |
? |
2.6.1.49 | 3-(3,4-dihydroxyphenyl)-L-alanine + 2-oxoglutarate |
i.e. L-dopa |
Homo sapiens |
3-(3,4-dihydroxyphenyl)pyruvate + L-glutamate |
i.e. DOPP |
? |
2.6.1.49 | 3-(3,4-dihydroxyphenyl)-L-alanine + 2-oxoglutarate |
i.e. L-dopa |
Rattus norvegicus |
3-(3,4-dihydroxyphenyl)pyruvate + L-glutamate |
i.e. DOPP |
? |
2.6.1.49 | 3-(3,4-dihydroxyphenyl)-L-alanine + 2-oxoglutarate |
most effective amino acceptor |
Cavia porcellus |
3-(3,4-dihydroxyphenyl)pyruvate + L-glutamate |
i.e. DOPP |
? |
2.6.1.49 | 3-(3,4-dihydroxyphenyl)-L-alanine + 3-phenylpyruvate |
i.e. L-dopa |
Homo sapiens |
3-(3,4-dihydroxyphenyl)pyruvate + L-phenylalanine |
- |
? |
2.6.1.49 | 3-(3,4-dihydroxyphenyl)-L-alanine + 3-phenylpyruvate |
i.e. L-dopa |
Rattus norvegicus |
3-(3,4-dihydroxyphenyl)pyruvate + L-phenylalanine |
- |
? |
2.6.1.49 | 3-(3,4-dihydroxyphenyl)-L-alanine + oxaloacetic acid |
- |
Rattus norvegicus |
3-(3,4-dihydroxyphenyl)pyruvate + L-aspartate |
- |
? |
2.6.1.49 | 3-(3,4-dihydroxyphenyl)-L-alanine + oxaloacetic acid |
i.e. L-Dopa, 10% of activity with 2-oxoglutarate |
Cavia porcellus |
3-(3,4-dihydroxyphenyl)pyruvate + L-aspartate |
- |
? |
2.6.1.49 | 3-(3,4-dihydroxyphenyl)pyruvate + L-aspartate |
aspartate-3,4-dihydroxyphenylpyruvate transaminase, ADT |
Alcaligenes faecalis |
3,4-dihydroxy-L-phenylalanine + oxaloacetate |
i.e. L-dopa |
? |
2.6.1.49 | 3-(3,4-dihydroxyphenyl)pyruvate + L-aspartate |
aspartate-3,4-dihydroxyphenylpyruvate transaminase, ADT |
Enterobacter cloacae |
3,4-dihydroxy-L-phenylalanine + oxaloacetate |
i.e. L-dopa |
? |